In this online CME self-learning program:
Enhanced recovery after surgery (ERAS) is a multimodal perioperative care pathway designed to attenuate the stress response during a patient’s surgical procedure and preserve organ function while promoting early recovery. While this approach is not new, it has not always been widely employed in spite of supporting evidence from a range of randomized controlled trials, systematic reviews, and meta-analyses. This literature suggests that ERAS programs are safe, cost-effective, and minimize the length of stay in a hospital without compromising quality of care. ERAS programs are successful in part because they are proactive in nature, comprised of interventions beginning during preoperative planning and continuing through intraoperative management and postoperative care. Although the evidence suggests that the multimodal, ERAS approach may be superior to conventional perioperative care, there are a number of challenges to the adoption of ERAS where it is not already used, including: resistance to change, variability between components and compliance to ERAS protocols, and the need for an engaged multidisciplinary team.
History of ERAS
Disadvantages of conventional care and advantages of ERAS
Preoperative ERAS in colorectal surgery
Intraoperative ERAS in colorectal surgery
Postoperative ERAS in colorectal surgery
Implementation of the ERAS program in colorectal surgery
Challenges facing the adoption of ERAS
This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is supported by Educational Grants from Edwards Lifesciences and Cubist Pharmaceuticals
Release Date: June 30, 2014 -- Expiration Date: June 30, 2016
Faculty: Sender Liberman, MD
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved through content review ScientiaCME.
Faculty Disclosure: Dr. Sender Liberman, MD discloses that he is a consultant / speaker for Merck.
Disclosures of Educational Planner: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC, which has received a grant from the commercial supporter of this program: Edwards Lifesciences and Cubist Pharmaceuticals.
Commercial Support Disclosure: This program is supported by an educational grant from Edwards Lifesciences, a manufacturer of medical devices and Cubist Pharmaceuticals
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.